Argenx
ARGX
#433
Rank
ยฃ40.12 B
Marketcap
ยฃ644.33
Share price
1.25%
Change (1 day)
29.25%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: ยฃ40.12 Billion

As of December 2025 Argenx has a market cap of ยฃ40.12 Billion. This makes Argenx the world's 433th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Argenx from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025ยฃ40.12 B34.46%
2024ยฃ29.84 B68.48%
2023ยฃ17.71 B2.25%
2022ยฃ17.32 B27.16%
2021ยฃ13.62 B32.44%
2020ยฃ10.28 B96.11%
2019ยฃ5.24 B89.91%
2018ยฃ2.76 B86.2%
2017ยฃ1.48 B
2014ยฃ93.47 M

End of Day market cap according to different sources

On Dec 16th, 2025 the market cap of Argenx was reported to be:

ยฃ38.81 Billion
by Nasdaq info icon info icon
ยฃ39.63 Billion
by CompaniesMarketCap info icon info icon